Filter
626
Filtered Results: 626
Text search:
nucleic
Acid
Featured
Recommendations
107
New Publications
156
Language
Document type
No document type
322
Guidelines
155
Studies & Reports
69
Manuals
42
Fact sheets
18
Strategic & Response Plan
7
Training Material
6
Infographics
3
Situation Updates
2
Resource Platforms
1
Videos
1
Countries / Regions
India
42
Western and Central Europe
19
Global
16
Africa
14
South Africa
11
Eastern Europe
11
Tanzania
9
Ethiopia
9
Latin America and the Carribbean
8
Brazil
8
Kenya
7
Nigeria
7
Nepal
6
East and Southern Africa
6
Liberia
6
Rwanda
5
Peru
5
West and Central Africa
5
Bangladesh
5
Zambia
5
Myanmar / Burma
5
Ukraine
4
Asia
4
Congo, Democratic Republic of
4
Eastern Europe and Central Asia
4
Russia
4
Angola
4
Colombia
3
El Salvador
3
Sierra Leone
3
Senegal
3
Germany
3
Middle East and North Africa
3
Argentina
3
Uganda
3
Namibia
3
China
2
Cameroon
2
Syria
2
Philippines
2
Guinea
2
Mozambique
2
South–East Asia Region
2
Portugal
2
Vietnam
2
Timor Leste/ East Timor
1
Lesotho
1
Turkey
1
Ghana
1
Burkina Faso
1
Afghanistan
1
Italy
1
USA
1
Haiti
1
Cambodia
1
Western Pacific Region
1
Uruguay
1
France
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Moldova
1
Sri Lanka
1
Georgia
1
Chad
1
Bhutan
1
Botswana
1
South Sudan
1
Indonesia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
76
Guidelines
50
COVID-19
37
TB
27
Hepatitis
19
HIV & STI
17
Virology
14
Studies & Reports
14
Capacity Building
14
Disease Prevention & Control
12
Women & Child Health
10
Parasitology
10
Bacteriology
9
Pediatrics
9
General Guidelines
7
Infection Control & Prevention (IPC)
7
Policies
7
Statistics
7
Paediatrics
5
Cervical Cancer
5
Gynaecology & Obstetrics
5
NTDs & Others
5
Dengue
5
Maternal Health
4
Malaria
4
Rabies
3
Hematology
3
Cancer
3
Vaccine-preventable Diseases
3
Clinical Guidelines
3
Drugs & Medical Equipment
3
Respiratory Infections
3
Non-communicable Diseases
3
Reproductive Health
3
Communicable Diseases
2
Pharmacy & Technology
2
Disaster Preparedness
2
Schistosomiasis
2
Laboratory Waste
2
Vector Control
2
Monitoring & Evaluation
2
MPOX - Monkeypox
2
Medical Devices & Equipment
2
Yellow Fever
2
Humanitarian Crisis
2
Quality Control & Assurance
2
Communicable Diseases
2
Health Systems
2
Leprosy
2
Leishmaniasis
2
Laboratory Quality Assurance
2
Water
2
Zika
1
Public Health
1
Helminthiasis
1
Emergency Health Kits
1
Yaws
1
Under-5 nutrition
1
Child Health
1
Diabetes
1
Gender
1
Lymphaticfilariasis
1
Humanitarian Aid
1
x MEDBOX Issue Brief & Annual Reports x
1
Breast Cancer
1
Cancer Treatment & Resources
1
TB
1
Maternal & Child Health
1
Public Health
1
Snakebites
1
Sexual Violence
1
Yersinia pestis (Plague)
1
Countries
1
Chagas
1
NCD
1
Cardiovascular Diseases
1
Hemorrhagic Fever
1
Training Manuals
1
Child protection
1
Palliative Care
1
Waste Management
1
Immunization
1
General Guidelines
1
Human African Trypanosomiasis
1
Neonatal Care
1
Toolboxes
Detection & Diagnosis
34
Diagnostics & Laboratory Guidance
30
Country specific documents
24
Clinical Guidelines
17
Drug resistant TB
14
Treatment & Prevention
12
Children & Adolescents
11
Clinical Aspects
10
Adults
10
Children
10
Surveillance & Contact tracing
10
HIV testing & services
9
Public Health
9
Prevention & Preparedness
8
Testing Guidelines
8
Surveillance
7
Prevention & Control
7
Laboratory
7
IPC
6
Infection Control General
6
Training
6
Policies & Strategies
5
Laboratory Guidance
5
Clinical Aspects, Treatment & Prevention
5
Hepatitis
5
Treatment Guidelines HIV
5
Laboratory
5
Treatment Guidelines
5
Training, others
5
TB/COVID-19
5
Inactivated COVID-19 Vaccines
5
Clinical Aspects & Diagnostics
5
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
5
TB & Prisoners
5
Disease Prevention & Control
5
Research & Access
5
TB/HIV Coinfection
5
HIV in Key Populations
5
Eastern Europe & Central Asia
5
Kenya
5
Reports & Studies
5
Preparedness & Prevention
5
Biosafety
4
ART Drug Resistance
4
Childhood TB
4
Ebola Prevention & Control
4
TB & Other Vulnerable Populations
4
Ethiopia
4
Prison & Detention
4
Access & Strategy
4
Clinical Aspects & Diagnostics
4
Overview, Studies & Reports
4
Access to treatment and laboratory
4
Prevention of mother-to-child transmission (PMTCT)
4
Clinical Guidelines
4
Antiretroviral Treatment ART
4
TB
4
Infection Control
4
Pregnant women
4
Eastern Europe and central Asia
4
Gynaecology / Obstetrics
3
Surveillance
3
Research
3
General
3
Clinical Guidelines
3
Clinical Aspects
3
Public Health
3
Global Impact: Socio-economic, health services, TB & HIV
3
Paediatrics
3
Hospital Readiness/Essential Health Services
3
Communication Material
3
Immunization Guidelines
3
TB/HIV
3
Genomic sequencing
3
Long COVID/ Post-COVID Syndrome
3
Biontech/Pfizer Comirnaty
3
Vaxzevria (Astra Zeneca)
3
Essential Medicines
3
Argentina
3
Waste Managment
3
MPOX - Monkeypox
3
Romania
3
Asia and Pacific
3
Dengue Prevention & Control
3
Zika Prevention & Control
3
HIV service delivery
3
Preparedness & Prevention
3
Rapid Response
2
Health Systems
2
Assessment & Studies
2
Moldova
2
Vaccines & Immunization
2
Influenza Prevention & Control
2
South Africa
2
Opportunistic Infections
2
WASH
2
Plague
2
Influenza
2
Dengue
2
Transgender People
2
Drug resistance
2
Surveillance
2
HIV
2
TB
2
Cholera Prevention & Control
2
Global
2
Prophylaxis
2
SOPs
2
Preparedness, Response & Risk Communication
2
Ebola
2
Country Guidelines
2
Workplace
2
Laboratory & Sampling
2
International
2
Context & Facts, Travel Advice
2
For General Public & Community
2
For Pregnant Women
2
Scientific & Research Studies
2
Blood Supply
2
Vaccine Candidates & Research
2
COVID-19 Vaccination
2
Non-pharmaceutical interventions (NPIs)
2
SARS-CoV-2 Variants
2
Moderna
2
Covaxin
2
Latin America
2
Rational use of Medicine
2
HIV &TB
2
One Health
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Studies & Reports
2
Women
2
General
2
Neurological Disorders
2
Assessment
2
Western & Central Europe
2
Laboratory & Diagnostics
2
Situation Reports, others
2
Meningitis & Encephalitis
2
Cholera Situation Reports
1
Behaviour Change/Life Skill Education
1
Meningitis Prevention & Control
1
TB & Drug Abuse
1
Agriculture & Veterinary
1
Clinical Guidelines
1
Chemical Attacks
1
Policies & Strategies
1
Yellow Fever
1
Preparedness, Response & Risk Communication
1
Key Resources
1
Clinical Guidelines
1
Zambia
1
WPRO (Western Pacific Region)
1
Prevention Guidelines
1
Context, Facts & Travel Advice
1
Children
1
HIV testing & disclosure
1
Namibia
1
Sexually Transmitted Infections
1
Eastern Europe
1
Others
1
People who injecting Drugs
1
Rwanda
1
Ebola & Marburg
1
Vaccination
1
Laboratory
1
Georgia
1
Drug resistance
1
Epilepsy
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Russia
1
Sex Worker
1
Communication & Training
1
Context & Facts
1
Studies
1
Health Personnel
1
General
1
COVID-19
1
PPE Personel Protective Equipment
1
Video & Audio
1
COVID-19 Information
1
For Health Worker
1
Clinical Guidelines
1
Country Specific
1
Gender Aspects
1
Physical Distancing
1
Child Protection
1
Infection Control & Prevention (IPC)
1
Essential Medicines & Medical Devices
1
Latin America
1
RCCE Guides & Manuals
1
Videos
1
Ebola Treatment Center
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Johnson & Johnson
1
Research & Pipeline
1
Waste Management
1
Palliative Care
1
Colombia
1
Overview
1
Peru
1
El Salvador
1
Resources Kreyol Earthquake Haiti
1
Food environments
1
Agriculture
1
Essential Medicines & Devices Lists
1
Pharmacy Practice
1
Supply Chain & Store Management
1
Quality Assurance
1
Traditional & Herbal Medicines
1
Cancer
1
Freshwater use
1
General documents One Health
1
General Guidelines for Rational Use
1
Pharmacovigilance
1
Guidelines & Manuals
1
Information Refugees Ukraine
1
Prevention & Measures
1
Zoonoses
1
COVID-19
1
Nuclear & Chemical Hazards
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
Chagas
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Policies & Strategies
1
Yaws & other Endemic Treponematoses
1
General Information & Methodology
1
Air Pollution
1
Armenia
1
Prevention & Strategies
1
Diagnosis
1
Botswana
1
Policies and guidelines
1
General
1
Co-Morbidities (except TB)
1
Zika
1
Technical Information
1
General Aspects
1
TB/HIV Global
1
Education of students & professionals
1
Nutrition
1
Technical Information
1
Roadmaps, Action Plans & Policies
1
Germany
1
Lesotho
1
Uganda
1
Stewardship
1
Latin America & the Carribean
1
Situation Reports
1
HIV and coinfection
1
IEC
1
Nigeria
1
Chikungunya Prevention & Control
1
Epidemiology
1
South-east Asia Region
1
Laboratory
1
Reports & Studies Children HIV
1
Paediatrics
1
Marburg Virus Situation Reports
1
Lobby and Advocacy
1
Epidemiology
1
Chikungunya
1
Case Definitions
1
Prisoners
1
Key Resources
1
Eastern and Southern Africa
1
Food & Nutrition
1
SEAR (South-east Asia Region)
1
Plague Prevention & Control
1
Treatment & Clinical Management
1
Surveillance Report
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
La presente publicación describe la evidencia científica publicada respecto a la hipertensión como factor pronóstico en pacientes con COVID-19. Se identificó una revisión sistemática que evaluó diferentes desenlaces de pronóstico en pacientes con hipertensión y diagnóstico confirmado de C...
La presente publicación describe la evidencia científica disponible sobre la utilidad del uso complementario de pruebas moleculares y de detección de anticuerpos para mejorar el diagnóstico de sospechosos de COVID-19. La utilización complementaria de ambas pruebas podría mejorar la identificac...
La presente publicación describe la evidencia científica disponible sobre la precisión diagnóstica de las pruebas rápidas de detección de antígenos para SARS-COV-2. El conocimiento de las pruebas diagnósticas para el coronavirus del síndrome respiratorio agudo grave 2 (SARS-COV-2) sigue evo...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include:
Community-based surveillance to detect symptomatic cases early for treatment and to avert viral transmission;
Sentinel surveillance in high-risk populations to detect ...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Updated Treatment Guidelines
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience...
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
